Personalis Inc. (PSNL)
NASDAQ: PSNL
· Real-Time Price · USD
6.45
0.44 (7.32%)
At close: Jun 16, 2025, 3:59 PM
6.45
0.08%
Pre-market: Jun 17, 2025, 05:12 AM EDT
7.32% (1D)
| Bid | 6.45 |
| Market Cap | 569.26M |
| Revenue (ttm) | 85.69M |
| Net Income (ttm) | -84.07M |
| EPS (ttm) | -1.29 |
| PE Ratio (ttm) | -5 |
| Forward PE | -6.46 |
| Analyst | Strong Buy |
| Ask | 6.69 |
| Volume | 1,380,071 |
| Avg. Volume (20D) | 750,176 |
| Open | 6.28 |
| Previous Close | 6.01 |
| Day's Range | 5.98 - 6.66 |
| 52-Week Range | 1.14 - 7.20 |
| Beta | 1.87 |
About PSNL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PSNL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PSNL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+21%
Personalis shares are trading higher after the com...
Unlock content with
Pro Subscription
5 months ago
+9.32%
Personalis shares are trading higher after the company and Moderna recently announced a multi-year extension to continue utilizing the Personalis ImmunoID NeXT platform and technology for V940/mRNA-4157. The company also announced an investment from Merck.
